| Literature DB >> 23637934 |
Wei Yan1, Li-Li Zhang, Li Yan, Feng Zhang, Ning-Bei Yin, Hong-Bin Lin, Chen-Yu Huang, Lei Wang, Jun Yu, Duen-Mei Wang, Zhen-Min Zhao.
Abstract
BACKGROUND: Photoaging is cumulative damage to skin, caused by chronic, repeated solar radiation exposure. Its molecular mechanisms are poorly understood at the level of global gene expression.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23637934 PMCID: PMC3634825 DOI: 10.1371/journal.pone.0061946
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Sample demographics.
| Subject_ID | Sample_ID | Age | BeadChip version |
| 1 | 1A, 1B | 40 | V2 |
| 2 | 2A, 2B | 38 | V2 |
| 3 | 3A, 3B | 40 | V2 |
| 4 | 4A, 4B | 47 | V2 |
| 5 | 5A, 5B | 50 | V2 |
| 6 | 6A, 6B | 50 | V2 |
| 7 | 7A, 7B | 55 | V2 |
| 8 | 8A, 8B | 53 | V2 |
| 9 | 9A, 9B | 55 | V2 |
| 10 | 10A, 10B | 46 | V3 |
| 11 | 11A, 11B | 46 | V3 |
| 12 | 12A, 12B | 50 | V3 |
| 13 | 13A, 13B | 34 | V3 |
| 14 | 14A, 14B | 38 | V3 |
| 15 | 15A, 15B | 42 | V3 |
| 16 | 16A, 16B | 44 | V3 |
| 17 | 17A, 17B | 44 | V3 |
| 18 | 18A, 18B | 46 | V3 |
| 19 | 19A, 19B | 52 | V3 |
| 20 | 20A, 20B | 47 | V3 |
| 21 | 21A, 21B | 53 | V3 |
A, pre-auricular skin sample; B, post-auricular skin sample.
V2, Illumina Human-6 V2 Expression BeadChip; V3, Illumina Human-6 V3 Expression BeadChip.
Primer sets and reaction conditions of Q-RT-PCR experiments.
| Gene | Primer sequences (Forward, Reverse) | Cycles | Annealing Tm (°C) | Product size (bp) |
|
| F: | 40 | 58 | 146 |
| R: | ||||
|
| F: | 40 | 58 | 122 |
| R: | ||||
|
| F: | 40 | 56 | 102 |
| R: | ||||
|
| F: | 40 | 52 | 118 |
| R: | ||||
|
| F: | 40 | 58 | 139 |
| R: | ||||
|
| F: | 40 | X | 150 |
| R:ACACGGAGTACTTGCGCTCAG |
X indicates that the annealing Tm of the gene ACTB could be 52, 56 or 58, according to the target genes.
Figure 1Heatmap of the top 100 shared DEGs identified by both GeneSpring and GSEA.
Group names are on top and gene symbols on the right.
Common enriched GO terms by the three software packages: WebGestalt, DAVID and GSEA.
| Regulation | Sub-category | Go term | P-value by WebGestalt | P-value by DAVID | FDR by GSEA |
|
|
| transmembrane receptor protein serine threonine kinase signaling pathway | 4.28e-4 | 1.43e-3 | 0.15 |
| transforming growth factor beta receptor signaling pathway | 6.83e-4 | 3.23e-4 | 0.17 | ||
| DNA replication | 7.20e-4 | 4.54e-3 | 0.15 | ||
| epidermis development | 5.32e-4 | 1.15e-6 | 0.18 | ||
| tissue development | 3.48e-3 | 2.23e-7 | 0.20 | ||
| ectoderm development | 1.09e-3 | 1.20e-6 | 0.20 | ||
| organ development | 2.03e-3 | 3.78e-8 | 0.23 | ||
|
| extracellular matrix | 1.48e-6 | 1.26e-6 | 0.08 | |
| extracellular matrix part | 1.27e-4 | 6.63e-5 | 0.10 | ||
| extracellular region part | 5.76e-5 | 1.27e-4 | 0.22 | ||
| basement membrane | 3.21e-3 | 3.64e-2 | 0.15 | ||
| cytoskeletal part | 4.83e14 | 4.75e-15 | 0.22 | ||
| intermediate filament cytoskeleton | 4.74e-26 | 9.72e-33 | 0.21 | ||
| intermediate filament | 4.74e-26 | 3.07e-32 | 0.22 | ||
| replication fork | 5.14e-4 | 3.77e-2 | 0.17 | ||
|
| NA | NA | NA | NA | |
|
|
| lipid metabolic process | 7.75e-11 | 1.3e-14 | 0.11 |
| carboxylic acid metabolic process | 1.15e-10 | 2.29e-12 | 0.05 | ||
| organic acid metabolic process | 1.36e-10 | 3.22e-12 | 0.06 | ||
| cellular lipid metabolic process | 4.10e-11 | 3.58e-11 | 0.07 | ||
| lipid biosynthetic process | 1.06e-9 | 4.49e-10 | 0.08 | ||
| fatty acid metabolic process | 1.46e-9 | 5.68e-8 | 0.07 | ||
| carbohydrate metabolic process | 1.31e-4 | 5.57e-7 | 0.17 | ||
| steroid metabolic process | 3.37e-4 | 7.84e-5 | 0.12 | ||
| generation of precursor metabolites and energy | 1.85e-7 | 5.26e-4 | 0.13 | ||
| fatty acid oxidation | 7.95e-5 | 5.99e-4 | 0.10 | ||
| glycolipid metabolic process | 1.93e-3 | 7.15e-4 | 0.15 | ||
| steroid biosynthetic process | 2.14e-4 | 1.06e-3 | 0.96 | ||
| excretion | 1.43e-5 | 5.60e-4 | 0.06 | ||
| amine catabolic process | 3.52e-5 | 5.50e-3 | 0.06 | ||
|
| endoplasmic reticulum | 3.35e-4 | 1.41e-7 | 0.17 | |
| endoplasmic reticulum part | 5.16e-3 | 4.65e-7 | 0.20 | ||
| cell fraction | 2.06e-4 | 4.92e-7 | 0.19 | ||
| membrane fraction | 3.38e-5 | 1.27e-6 | 0.20 | ||
| intrinsic to organelle membrane | 1.38e-5 | 2.57e-6 | 0.15 | ||
| endoplasmic reticulum membrane | 1.82e-3 | 9.08e-6 | 0.17 | ||
| intrinsic to endoplasmic reticulum membrane | 7.22e-5 | 1.12e-5 | 0.11 | ||
| organelle membrane | 1.45e-3 | 7.82e-5 | 0.20 | ||
| integral to organelle membrane | 1.38e-5 | 1.06e-4 | 0.21 | ||
| integral to endoplasmic reticulum membrane | 4.61e-3 | 1.87e-3 | 0.22 | ||
| nuclear envelope-endoplasmic reticulum network | 2.92e-3 | 1.04e-5 | 0.19 | ||
|
| oxidoreductase activity | 2.12e-10 | 4.75e-12 | 0.08 | |
| lyase activity | 1.10e-3 | 1.70e-4 | 0.22 | ||
| monooxygenase activity | 2.16e-3 | 9.68e-4 | 0.14 | ||
| anion channel activity | 3.05e-3 | 3.88e-2 | 0.11 |
Up, up-regulation; Down, down-regulation.
BP, biological progress; CC, cell component; MF, molecular function.
NA, not available.
Common enriched KEGG pathways by the three software packages: WebGestalt, DAVID and GSEA.
| Regulation | Pathway name | P-value by WebGestalt | P-value by DAVID | FDR by GSEA |
|
| ECM-receptor interaction | 7.86e-7 | 1.72e-4 | 0.16 |
| TGF-beta signaling pathway | 3.37e-5 | 4.15e-3 | 0.13 | |
| Cell cycle | 1.87e-3 | 5.12e-2 | 0.13 | |
|
| Valine, leucine and isoleucine degradation | 1.77e-7 | 2.39e-4 | 0.13 |
| Arginine and proline metabolism | 3.72e-6 | 1.44e-2 | 0.10 | |
| Fructose and mannose metabolism | 1.27e-5 | 3.46e-3 | 0.09 | |
| Glycolysis / Gluconeogenesis | 1.09e-6 | 5.80E-2 | 0.14 | |
| Glycosphingolipid biosynthesis – ganglio series | 1.20e-5 | 7.08e-3 | 0.12 | |
| Tryptophan metabolism | 1.84e-5 | 3.67e-2 | 0.15 | |
| Arachidonic acid metabolism | 4.17e-5 | 3.56e-2 | 0.11 | |
| Nitrogen metabolism | 2.09e-4 | 4.76e-2 | 0.14 |
The related enriched pathways in other databases.
| Regulation | Pathway database | Pathway name | P-value/FDR | Software package |
|
| REACTOME_PATHWAY | Cell cycle, Mitotic | 8.88e-4 | DAVID |
| REACTOME_PATHWAY | Signaling by BMP | 3.32e-2 | DAVID | |
| GenMAPP | DNA replication reactome | 0.23 | GSEA | |
| GenMAPP | G1 to S cell cycle reactome | 0.25 | GSEA | |
| BIOCARTA | Cell cycle:G2/M Checkpoint | 0.03 | GSEA | |
| BIOCARTA | Effects of calcineurin in Keratinocyte Differentiation | 0.11 | GSEA | |
| BIOCARTA | Cell cycle:G1/S Checkpoint | 0.13 | GSEA | |
| BIOCARTA | Cyclins and Cell Cycle Regulation | 0.14 | GSEA | |
|
| BIOCARTA | Catabolic Pathways for Arginine, Histidine, Glutamate, Glutamine, and Proline | 3.69e-2 | DAVID |
| REACTOME_PATHWAY | Metabolism of amino acids | 7.85e-4 | DAVID | |
| REACTOME_PATHWAY | Metabolism of carbohydrates | 8.25e-4 | DAVID | |
| REACTOME_PATHWAY | Metabolism of lipids and lipoproteins | 8.81e-4 | DAVID | |
| GenMAPP | Arginine and proline metabolism | 0.07 | GSEA | |
| GenMAPP | Nitrogen metabolism | 0.10 | GSEA | |
| GenMAPP | Tryptophan metabolism | 0.08 | GSEA | |
| GenMAPP | Glycolysis and gluconeogenesis | 0.10 | GSEA | |
| GenMAPP | Glycolysis | 0.14 | GSEA | |
| GenMAPP | Gluconeogenesis | 0.14 | GSEA | |
| GenMAPP | Fructose and mannose metabolism | 0.13 | GSEA | |
| GenMAPP | Valine leucine and isoleucine degradation | 0.15 | GSEA |
Up, up-regulation; Down, down-regulation.
P-value for results by DAVID, FDR for results by GSEA.
Figure 2Modified “TGF-beta signaling pathway” from KEGG.
Protein symbols were replaced by gene symbols to reflect gene-based data. For better legibility, gene symbols were not italicized. See the online information http://www.genome.jp/kegg/document/help_pathway.html for detailed KEGG pathway map notation.
Figure 3Modified “Valine, leucine and isoleucine degradation” pathway from KEGG.
Protein symbols were replaced by gene symbols to reflect gene-based data. For better legibility, gene symbols were not italicized. See the online information http://www.genome.jp/kegg/document/help_pathway.html for detailed KEGG pathway map notation.
Figure 4Expression concordance between microarray and Q-RT-PCR assays.
The X-axis indicates the examined genes. The Y-axis represents the fold changes (FC) of expression values between the pre-auricular skin and post-auricular skin. For better legibility, gene symbols were not italicized.